Find latest Myeloma videos
·
100+ videos
Playback speed
10 seconds
AACR 2024 Insights: "Linvoseltamab, a BCMA-Targeted BsAb, in Pts With R/R Myeloma Including Difficult-to-Treat Subgroups"
By
Icahn School of Medicine at Mount Sinai
FEATURING
Sundar Jagannath
By
Icahn School of Medicine at Mount Sinai
FEATURING
Sundar Jagannath
64 views
May 2, 2024
Comments 0
Login to view comments.
Click here to Login